Latest News
- Freight Surge and Gulf Tensions Threaten India’s Pharma Exports; Industry Flags Potential ?5,000-Crore Impact
- Min. Nadda Unveils ?13,000-Crore Bio-Pharma SHAKTI and Chemical Parks Push to Expand India’s Global Chemicals and Biologics Footprint
- Aurobindo Pharma Subsidiary Launches Generic Cancer Drug in US, Expands Oncology Portfolio in Global Generics Market
WHO Hails India’s National Health AI Strategy as a ‘Global Benchmark’
World Health Organization praises India’s health AI blueprint as a pioneering roadmap for safe, ethical, and inclusive AI adoption in healthcare.
- By PharmaNews Live Desk
- New Delhi
- Feb 19, 2026
India’s newly unveiled National Health Artificial Intelligence Strategy has earned high praise from the World Health Organization (WHO), which described it as a global benchmark for other nations looking to responsibly integrate AI into health systems. The comments came during the ongoing India AI Impact Summit 2026 in New Delhi, where global health leaders and policymakers are discussing advancements in digital health technologies.
WHO Endorses India’s Leadership on Health AI
Dr Catharina Boehme, WHO’s Assistant Director-General for Digital Health and Innovation, underscored India’s pioneering role in crafting a comprehensive national strategy for health AI. She said India is among the first countries globally — and the first in the WHO South-East Asia region — to formally adopt such a strategy, positioning it as a model for robust, equitable AI governance in health.
Boehme noted that the strategy aligns with global efforts to ensure AI technologies enhance screening, diagnosis, disease surveillance, and care delivery while balancing ethical and safety considerations.
A Strategic Framework for Responsible AI in Healthcare
India’s National Health AI Strategy builds on earlier policy frameworks, including the broader National Strategy for Artificial Intelligence and recent health sector initiatives that emphasize interoperability, data privacy and public benefit.
At the summit, Union Health Minister Jagat Prakash Nadda launched two major components of the strategy — the Strategy for Artificial Intelligence in Healthcare for India (SAHI) and the Benchmarking Open Data Platform for Health AI (BODH) — aimed at establishing ethical, transparent, and accountable frameworks for AI deployment across the health ecosystem.
From Policy to Practice: Vision for Scalable Impact
Officials at the summit highlighted that India’s approach goes beyond experimentation, providing clear guidance on governance, validation and scalability of AI tools in clinical and public health contexts. The BODH platform, developed in collaboration with academic partners such as IIT Kanpur, allows AI models to be benchmarked against real-world data in a privacy-preserving manner, reinforcing trust and effectiveness.
Experts say these measures signal a shift toward structured and evidence-based AI integration in areas ranging from diagnostics to health service delivery, supporting broader goals of quality, access and equity in healthcare.
Global and Regional Implications
WHO’s endorsement reflects broader recognition of the importance of governance, ethics and inclusivity in AI’s evolution within health systems worldwide. India’s prominence in this space may encourage other low- and middle-income countries to adopt similarly comprehensive AI strategies tailored to their public health priorities.
As AI applications continue to expand — from disease risk prediction and telemedicine to personalised care pathways — global health stakeholders are watching India’s experience for lessons on balancing innovation with robust oversight and societal benefit.